Microlife - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 3,145,543 | 3,161,241 | 3,673,967 | 3,620,247 | 4,072,407 | 3,883,920 | 4,060,529 | 4,465,869 |
| Profit before tax | 211,161 | 362,364 | 335,532 | 320,991 | 96,246 | 387,280 | 225,805 | 202,611 |
| Net profit | 168,448 | 319,587 | 278,713 | 269,085 | 53,068 | 347,060 | 198,010 | 174,690 |
| Equity | 1,730,968 | 2,050,555 | 2,329,268 | 2,598,353 | 2,651,421 | 2,998,481 | 2,446,491 | 2,621,181 |
| Liabilities | 523,354 | 295,499 | 590,949 | 587,999 | 363,086 | 789,441 | 500,731 | 880,640 |
| Non-current assets | 1,221 | 13,311 | 8,257 | 9,522 | 6,328 | 3,877 | 3,324 | 1,214 |
| Current assets | 2,244,104 | 2,324,294 | 2,906,205 | 3,178,847 | 3,012,427 | 3,785,759 | 2,960,864 | 3,503,625 |
| Total assets | 2,245,325 | 2,337,605 | 2,914,462 | 3,188,369 | 3,018,755 | 3,789,636 | 2,964,188 | 3,504,839 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 317,213 | 313,993 | 354,778 |
| Social insurance contributions | - | - | - | - | - | 45,029 | 46,908 | 46,701 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +1.8% | +0.5% | +16.2% | -1.5% | +12.5% | -4.6% | +4.5% | +10.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 7.5% | 13.7% | 9.6% | 8.4% | 1.8% | 9.2% | 6.7% | 5.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 9.7% | 15.6% | 12.0% | 10.4% | 2.0% | 11.6% | 8.1% | 6.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 5.4% | 10.1% | 7.6% | 7.4% | 1.3% | 8.9% | 4.9% | 3.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 6.7% | 11.5% | 9.1% | 8.9% | 2.4% | 10.0% | 5.6% | 4.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.3 | 0.1 | 0.3 | 0.2 | 0.1 | 0.3 | 0.2 | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 524,257 | 526,874 | 612,328 | 603,375 | 678,735 | 685,394 | 676,755 | 744,312 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Microlife - Social security debts
The company had no debts to Sodra
Microlife - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Microlife, UAB (code 111834071) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €4.47M, up 10.0% year on year and 15.0% over two years. Net profit was €174.7K, after €198.0K in 2024 and €347.1K in 2023, showing that profitability has eased while sales continued to grow. The net profit margin declined from 8.9% in 2023 to 4.9% in 2024 and 3.9% in 2025. At the latest year-end, total assets amounted to €3.50M, equity to €2.62M, and liabilities to €880.6K. The equity ratio was 74.8% and debt-to-equity 0.34, indicating a conservative balance sheet structure. Asset turnover stood at 1.27x, ROE at 6.7%, and ROA at 5.0% in 2025. Revenue per employee reached €744.3K and profit per employee €29.1K, reflecting a relatively productive operating profile.